Alina Hegheș

Dr. Alina Hegheș


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
GMGeorgiana Viorica Moise
Georgiana Viorica Moise
Alex Robert JijieAlex Robert Jijie
Alex Robert Jijie
Elena Alina MoacaElena Alina Moaca
Elena Alina Moaca
IPIasmina-Alexandra Predescu
Iasmina-Alexandra Predescu
CRISTINA ADRIANA DEHELEANCRISTINA ADRIANA DEHELEAN
CRISTINA ADRIANA DEHELEAN
CVCristian Sebastian Vlad
Cristian Sebastian Vlad
Background: Plants have long been recognized for their potential to influence neurological health, with both neuroprotective and neurotoxic properties. This review explores the dual nature of plant-derived compounds and their impact on the human brain. Discussion: Numerous studies have highlighted the neuroprotective effects of various phytoconstituents, such as those found in Ginkgo biloba, Centella asiatica, Panax ginseng, Withania somnifera, and Curcuma longa. The neuroprotective compounds have demonstrated antioxidant, anti-inflammatory, and cognitive-enhancing properties, making them promising candidates for combating neurodegenerative diseases and improving brain function. Polyphenolic compounds, triterpenic acids, and specific phytocompounds like the ones from EGb 761 extract have shown interactions with key enzymes and receptors in the brain, leading to neuroprotective outcomes. However, this review also acknowledges the neurotoxic potential of certain plants, such as the Veratrum species, which contains steroidal alkaloids that can cause DNA damage and disrupt neurological function, or Atropa belladonna, which interfere with the normal functioning of the cholinergic system in the body, leading to a range of symptoms associated with anticholinergic toxicity. Conslusions: This review also emphasizes the need for further research to elucidate the complex mechanisms underlying the neuroprotective and neurotoxic effects of plant-derived compounds, as well as to identify novel phytoconstituents with therapeutic potential. Understanding the complex relationship between plants and the human brain is crucial for harnessing the benefits of neuroprotective compounds while mitigating the risks associated with neurotoxic substances. This review provides a comprehensive overview of the knowledge on the neurological properties of plants and highlights the importance of continued research in this field for the development of novel therapeutic strategies targeting brain health and neurological disorders.

10 April 2013 in BMC Chemistry
Verified
Journal Article
Open access
PDF file
AHAlina Hegheș
Alina Hegheș
Codruta SoicaCodruta Soica
Codruta Soica
SASimona Ardelean
Simona Ardelean
Rita AmbrusRita Ambrus
Rita Ambrus
Danina Mirela MunteanDanina Mirela Muntean
Danina Mirela Muntean
Florin BorcanFlorin Borcan
Florin Borcan
Background: Emulsifiers have a significant role in the emulsion polymerization by reducing the interfacial tension thus increasing the stability of colloidal dispersions of polymer nanostructures. This study evaluates the impact of four emulsifiers on the characteristics of polyurethane hollow structures used as drug delivery system. Results: Polyurethane (PU) structures with high stability and sizes ranging from nano- to micro-scale were obtained by interfacial polyaddition combined with spontaneous emulsification. The pH of PU aqueous solutions (0.1% w/w) was slightly acidic, which is acceptable for products intended to be used on human skin. Agglomerated structures with irregular shapes were observed by scanning electron microscopy. The synthesized structures have melting points between 245-265°C and reveal promising results in different evaluations (TEWL, mexametry) on murine skin. Conclusions: In this study hollow PU structures of reduced noxiousness were synthesized, their size and stability being influenced by emulsifiers. Such structures could be used in the pharmaceutical field as future drug delivery systems.

Verified
Journal Article
Open access
PDF file
Laura MaghiarLaura Maghiar
Laura Maghiar
Paula MaghiarPaula Maghiar
Paula Maghiar
Laurean Ovidiu PopLaurean Ovidiu Pop
Laurean Ovidiu Pop
ACAnca-Maria Căpraru
Anca-Maria Căpraru
MMMihaela Mirela Muresan
Mihaela Mirela Muresan
AHAlina Hegheș
Alina Hegheș
Chronic wounds represent a growing global healthcare burden driven by persistent inflammation, polymicrobial biofilm formation, impaired tissue regeneration, and increased antimicrobial resistance. This review examines the mechanistic interplay between chronic wound pathophysiology, biofilm persistence, and antimicrobial peptide (AMP)-based therapeutics, with particular emphasis on translational barriers and advanced biomaterial-enabled delivery strategies. Current evidence demonstrates that AMPs exert multifactorial activities extending beyond direct antimicrobial effects, including membrane disruption, quorum-sensing inhibition, extracellular polymeric substance (EPS) destabilization, immune modulation, angiogenic stimulation, and promotion of re-epithelialization. However, their clinical translation remains limited due to proteolytic degradation, poor stability, cytotoxicity, rapid clearance, and inadequate retention within the hostile chronic wound microenvironment. To address these limitations, emerging biomaterial platforms—including hydrogels, electrospun nanofibers, nanoparticles, self-assembling peptide systems, and stimuli-responsive smart dressings—have been developed to improve AMP stability, controlled release, biofilm penetration, and regenerative efficacy. This review further highlights current preclinical and clinical challenges, including the lack of standardized polymicrobial biofilm models and translationally relevant wound systems, while discussing future perspectives such as artificial intelligence-assisted peptide design and precision wound therapeutics. We argue that peptide discovery is no longer the principal bottleneck: the rate-limiting steps are now peptide stabilization, biofilm-targeted delivery, and dosing, and no current platform yet couples validated eradication of mature polymicrobial biofilms with validated tissue regeneration in a clinically representative model. Collectively, AMP-enabled smart biomaterials may support the transition from passive wound management toward responsive, biofilm-targeted regenerative therapy.

Verified
Journal Article
Open access
PDF file
MAmhd kher alsaeyd ahmad
mhd kher alsaeyd ahmad
DCDoina Chioran
Doina Chioran
DPDana Emanuela T Pitic
Dana Emanuela T Pitic
Elena Alina MoacaElena Alina Moaca
Elena Alina Moaca
DADiana Haj Ali
Diana Haj Ali
MVMirela Voicu
Mirela Voicu
Background/Objectives: Plant-mediated silver nanoparticles (AgNPs) are promising components for oral biomaterials because of their antimicrobial potential; however, their biological behavior depends strongly on the phytochemical matrix, physicochemical characteristics, and exposure concentration. This study aimed to evaluate silver nanoparticles formulations synthesized using turmeric powder-derived Curcuma longa ethanolic and aqueous extracts, with emphasis on physicochemical characterization, antibacterial activity against oral-relevant Gram-positive bacteria, cytocompatibility toward human gingival fibroblasts (HGF-1), and acute in ovo vascular compatibility. Methods: AgCUR-EtOH NPs and AgCUR-H2O NPs were synthesized using CUR-EtOH and CUR-H2O extracts as reducing and stabilizing matrices. The resulting formulations were characterized by UV–visible spectroscopy (UV-Vis), dynamic light scattering (DLS), zeta-potential analysis, X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), transmission electron microscopy (TEM), and energy-dispersive X-ray spectroscopy (EDX). Minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) were determined against Streptococcus mutans, Streptococcus oralis, and Staphylococcus aureus. Cytocompatibility was evaluated in HGF-1 human gingival fibroblasts after 24 h exposure to 1–10 µg/mL using complementary viability, lysosomal, mitochondrial, and fluorescence-based assays. Acute vascular irritation was assessed using the hen’s egg test–chorioallantoic membrane (HET-CAM) assay. Results: Both formulations exhibited broad, polydisperse hydrodynamic distributions and negative apparent zeta potentials. AgCUR-H2O NPs showed a lower Z-average diameter than AgCUR-EtOH NPs under their respective solvent-specific measurement conditions. XRD pattern revealed heterogeneous crystalline compositions dominated by residual AgNO3, together with weaker contributions consistent with metallic Ag and a possible minor oxidized silver phase. FTIR spectra demonstrated extract-derived organic functional groups and prominent nitrate-associated bands. TEM/EDX confirmed Ag-containing nanostructures with approximate size ranges of 15–175 nm for AgCUR-EtOH NPs and 15–150 nm for AgCUR-H2O NPs. S. mutans was the most susceptible microorganism, with MIC values of 9 and 7 µg/mL and MBC values of 88 and 62 µg/mL for AgCUR-EtOH NPs and AgCUR-H2O NPs, respectively. AgCUR-H2O NPs consistently showed lower MIC and MBC values against all tested strains, but also produced a more pronounced concentration-dependent reduction in HGF-1 viability. At 10 µg/mL, cell viability was 71.88% for AgCUR-EtOH NPs and 52.14% for AgCUR-H2O NPs. Both formulations showed low acute irritation potential in ovo, with irritation scores of 1.06 and 0.69, respectively. Conclusions: The two CUR-AgNP formulations exhibited distinct physicochemical, antibacterial, and cellular response profiles under the tested conditions. At equivalent concentrations expressed as total dried formulation mass, AgCUR-H2O NPs yielded lower MIC and MBC values against the tested bacterial strains, whereas AgCUR-EtOH NPs produced a less pronounced reduction in HGF-1 viability. Because the powders were not quantitatively normalized for total silver, extract-derived organic fraction, or residual precursor content, these differences cannot be attributed exclusively to nanoparticle properties or to the extraction solvent and should not be interpreted as evidence of the intrinsic superiority of either formulation. Both formulations showed low acute vascular irritation. Further quantitative compositional, silver-release, and biofilm assessments are required before incorporation into oral biomaterial platforms.

22 October 2026 in Diseases
Verified
Journal Article
Open access
PDF file
OSOana Silvana Sarau
Oana Silvana Sarau
DCDespina Calamar-Popovici
Despina Calamar-Popovici
DODacian Nicolae Oros
Dacian Nicolae Oros
DCDoina Chioran
Doina Chioran
DHDelia Ioana Horhat
Delia Ioana Horhat
HBHoria Silviu Branea
Horia Silviu Branea
Background: Non-Hodgkin lymphoma (NHL) involving the ear, nose, and throat (ENT) region comprises a heterogeneous group of nodal and extranodal lymphoid malignancies with distinct clinicopathological features. This review aimed to provide an integrated overview of clinical presentation, pathology, diagnostic workup, staging, and treatment. Methods: A structured narrative search of PubMed, ScienceDirect, MDPI, and Google Scholar covered publications from January 2015 to July 2026; earlier landmark studies were included when clinically pivotal. Evidence was synthesized by histological subtype, anatomical site, and three pragmatic patterns of ENT involvement: primary extranodal ENT lymphoma, cervical nodal or Waldeyer’s ring presentation, and secondary ENT involvement in systemic disease. An exploratory keyword co-occurrence analysis of 2732 Scopus-indexed publications (2015–2026) was performed using VOSviewer. Results: The review focuses on diffuse large B-cell lymphoma, extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue, follicular lymphoma, extranodal NK/T-cell lymphoma, and mantle cell lymphoma. ENT manifestations are often non-specific and may mimic inflammatory, infectious, or epithelial disorders. Diagnosis requires adequate tissue sampling and integrated assessment of morphology, immunophenotype, imaging, and, when indicated, molecular or virus-associated studies. Treatment is guided by histological subtype, systemic stage, biological risk, previous therapy, and patient fitness, while anatomical site influences biopsy planning, local complications, radiotherapy, and functional preservation. Bibliometric mapping showed interconnected clinicopathological and therapeutic themes with increasing emphasis on molecular, biomarker, and immunotherapy-related research. Conclusions: NHL involving the ENT region should not be approached as a homogeneous entity. The three-pattern framework may facilitate diagnostic evaluation, staging, treatment planning, and multidisciplinary management.